Patents by Inventor Julia Fassbender

Julia Fassbender has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12060409
    Abstract: The present invention relates to short cyclic peptides, their use in the treatment, amelioration or prevention of a disease caused by antibodies targeting the thyrotropin-TSH receptor (TSHR) in the thyroid gland, in particular Graves' disease and orbitopathy, and to pharmaceutical compositions comprising the same.
    Type: Grant
    Filed: September 13, 2019
    Date of Patent: August 13, 2024
    Assignee: ADVANCECOR GMBH
    Inventors: Julia Fassbender, Hans-Peter Holthoff, Zhongmin Li, Martin Ungerer
  • Patent number: 11459375
    Abstract: The present invention relates to a cyclic peptide, its use in the treatment, amelioration or prevention of a disease caused by antibodies targeting the thyrotropin-TSH receptor (TSHR) in the thyroid gland, in particular Graves' disease and orbitopathy, and to pharmaceutical compositions comprising the same.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: October 4, 2022
    Assignee: advanceCOR GmbH
    Inventors: Hans-Peter Holthoff, Martin Ungerer, Julia Fassbender, Zhongmin Li
  • Publication number: 20220041692
    Abstract: The present invention relates to short cyclic peptides, their use in the treatment, amelioration or prevention of a disease caused by antibodies targeting the thyrotropin-TSH receptor (TSHR) in the thyroid gland, in particular Graves' disease and orbitopathy, and to pharmaceutical compositions comprising the same.
    Type: Application
    Filed: September 13, 2019
    Publication date: February 10, 2022
    Inventors: Julia Fassbender, Hans-Peter Holthoff, Zhongmin Li, Martin Ungerer
  • Publication number: 20200071384
    Abstract: The present invention relates to a cyclic peptide, its use in the treatment, amelioration or prevention of a disease caused by antibodies targeting the thyrotropin-TSH receptor (TSHR) in the thyroid gland, in particular Graves' disease and orbitopathy, and to pharmaceutical compositions comprising the same.
    Type: Application
    Filed: February 28, 2018
    Publication date: March 5, 2020
    Applicant: advanceCOR GmbH
    Inventors: Hans-Peter Holthoff, Martin Ungerer, Julia Fassbender, Zhongmin Li